Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Forschner

Showing results (31-40 of 157) with videos related to

Pageof 16
Sort By:
Journal of Cancer Research and Clinical Oncology|January 18, 2024
Long-term survival of stage IV melanoma patients: evaluation on 640 melanoma patients entering stage IV between 2014 and 2017Markus Reitmajer, Ulrike Leiter, Lena Nanz, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 11, 2020
Toxic epidermal necrolysis in a melanoma patient under targeted therapy with encorafenib and binimetinibNina Lang, Chiara Giulia Schinaia, Frederik Wolfsperger, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 28, 2020
Nina Lang, Chiara Giulia Schinaia, Frederik Wolfsperger, et al.
Cancers|November 13, 2021
Individualized Proteogenomics Reveals the Mutational Landscape of Melanoma Patients in Response to ImmunotherapyMarisa Schmitt, Tobias Sinnberg, Heike Niessner, et al.
Journal of Translational Medicine|August 27, 2025
GeneBits: ultra-sensitive tumour-informed ctDNA monitoring of treatment response and relapse in cancer patientsJulian Broche, Olga Kelemen, Aishwarya Sekar, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 9, 2009
G-DRG Version 2009: new developmentsMarcel L Müller, Andrea Forschner, Andreas Wenke, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 6, 2021
Is there an overtreatment of melanoma patients at the end of their life? Results of a multicenter study on 193 melanoma patientsAndrea Forschner, Carmen Loquai, Frank Meiss, et al.
The Australasian Journal of Dermatology|February 13, 2020
Absolute and relative differential blood count predicts survival of AJCC stage I-II melanoma patients scheduled for sentinel lymph node biopsyNikolaus B Wagner, Felix Luttermann, Maximilian Gassenmaier, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 6, 2017
Pembrolizumab-induced hepatitis: diagnosis and treatmentAndrea Forschner, Christina Schraml, Kathrin Pierchalla, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 6, 2017
Durch Pembrolizumab verursachte Hepatitis: Diagnose und BehandlungAndrea Forschner, Christina Schraml, Kathrin Pierchalla, et al.
Pageof 16

Showing results (31-40 of 157) with videos related to

Sort By:
Pageof 16
Journal of Cancer Research and Clinical Oncology|January 18, 2024
Long-term survival of stage IV melanoma patients: evaluation on 640 melanoma patients entering stage IV between 2014 and 2017Markus Reitmajer, Ulrike Leiter, Lena Nanz, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 11, 2020
Toxic epidermal necrolysis in a melanoma patient under targeted therapy with encorafenib and binimetinibNina Lang, Chiara Giulia Schinaia, Frederik Wolfsperger, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 28, 2020
Nina Lang, Chiara Giulia Schinaia, Frederik Wolfsperger, et al.
Cancers|November 13, 2021
Individualized Proteogenomics Reveals the Mutational Landscape of Melanoma Patients in Response to ImmunotherapyMarisa Schmitt, Tobias Sinnberg, Heike Niessner, et al.
Journal of Translational Medicine|August 27, 2025
GeneBits: ultra-sensitive tumour-informed ctDNA monitoring of treatment response and relapse in cancer patientsJulian Broche, Olga Kelemen, Aishwarya Sekar, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 9, 2009
G-DRG Version 2009: new developmentsMarcel L Müller, Andrea Forschner, Andreas Wenke, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 6, 2021
Is there an overtreatment of melanoma patients at the end of their life? Results of a multicenter study on 193 melanoma patientsAndrea Forschner, Carmen Loquai, Frank Meiss, et al.
The Australasian Journal of Dermatology|February 13, 2020
Absolute and relative differential blood count predicts survival of AJCC stage I-II melanoma patients scheduled for sentinel lymph node biopsyNikolaus B Wagner, Felix Luttermann, Maximilian Gassenmaier, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 6, 2017
Pembrolizumab-induced hepatitis: diagnosis and treatmentAndrea Forschner, Christina Schraml, Kathrin Pierchalla, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 6, 2017
Durch Pembrolizumab verursachte Hepatitis: Diagnose und BehandlungAndrea Forschner, Christina Schraml, Kathrin Pierchalla, et al.
Pageof 16